XML 45 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Intangible Assets and Goodwill
3 Months Ended
Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill

9. Intangible Assets and Goodwill

Intangible Assets

The following table presents the Company’s intangible assets at March 31, 2020 and December 31, 2019 (in thousands):

 

 

 

March 31, 2020

 

 

Gross Carrying

Value

 

 

Accumulated Amortization

 

 

ASC 842

Adjustment

 

 

Total

 

 

Estimated

useful life

Acquired intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed product rights for Auryxia

 

$

329,130

 

 

$

(47,018

)

 

$

 

 

$

282,112

 

 

9 Years

Favorable lease

 

 

545

 

 

 

(5

)

 

 

(540

)

 

 

 

 

N/A

Total

 

$

329,675

 

 

$

(47,023

)

 

$

(540

)

 

$

282,112

 

 

 

 

 

 

December 31, 2019

 

 

Gross Carrying

Value

 

 

Accumulated

Amortization

 

 

ASC 842

Adjustment

 

 

Total

 

 

Estimated

useful life

Acquired intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed product rights for Auryxia

 

$

329,130

 

 

$

(37,918

)

 

$

 

 

$

291,212

 

 

9 Years

Favorable lease

 

 

545

 

 

 

(5

)

 

 

(540

)

 

 

 

 

N/A

Total

 

$

329,675

 

 

$

(37,923

)

 

$

(540

)

 

$

291,212

 

 

 

 

On December 12, 2018, the Company completed the Merger, whereby it acquired certain definite-lived intangible assets, including the developed product rights for Auryxia and a favorable lease. The Company amortizes its definite-lived intangible assets acquired as part of the Merger using the straight-line method, which is considered the best estimate of economic benefit, over its estimated useful life. As a result of the adoption of ASC 842 on January 1, 2019, the Company reclassed the remaining balance of the favorable lease intangible asset into the operating lease asset. The Company recorded $9.1 million in amortization expense related to the developed product rights for Auryxia during each of the three months ended March 31, 2020 and 2019. Estimated future amortization expense for the intangible asset as of March 31, 2020 is as follows (in thousands):

 

 

 

Total

 

2020

 

$

27,302

 

2021

 

 

36,401

 

2022

 

 

36,402

 

2023

 

 

36,401

 

2024

 

 

36,402

 

Thereafter

 

 

109,204

 

 

 

$

282,112

 

 

Goodwill

Goodwill was $55.1 million as of March 31, 2020 and December 31, 2019, derived as follows (in thousands):

 

Total Merger consideration

 

$

527,754

 

Less: Fair value of identified acquired assets and liabilities, net

 

 

(472,701

)

Goodwill

 

$

55,053

 

 

Goodwill is evaluated for impairment on an annual basis as of October 1, and more frequently if indicators are present or changes in circumstances suggest that an impairment may exist.